Timothy L. Jackson
Papers
1
Total Citations
12
H-Index
1
About
Timothy L. Jackson is a leading ophthalmologist and researcher whose work focuses on the treatment of retinal diseases, particularly neovascular age-related macular degeneration (nAMD). His most significant contribution is the pivotal STAR trial, a randomised, double-masked, sham-controlled device study evaluating stereotactic radiotherapy for nAMD. This work demonstrated that a single, precisely targeted radiation treatment can reduce the burden of frequent anti-VEGF injections while maintaining vision, offering a transformative alternative for patients. The STAR trial, published in 2024, has already garnered 12 citations, reflecting its immediate impact on the field. Jackson’s research bridges the gap between radiation oncology and ophthalmology, addressing the pathogenic processes underlying nAMD, such as inflammation and angiogenesis. His work is notable for its rigorous methodology and patient-centred outcomes, positioning him as a key figure in advancing non-invasive therapies for blinding eye diseases.
Research Focus
Key Achievements
Top Papers
- 1